Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design

Changning Guo1, Keith J Stine, John F Kauffman

  • 1Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, MO 63101, United States. changning.guo@fda.hhs.gov